Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

NACompletedINTERVENTIONAL
Enrollment

404

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
CVA (Cerebrovascular Accident)Cerebral HemorrhageIntracranial Hemorrhages
Interventions
DRUG

Labetalol Hydrochloride

DRUG

Metoprolol tartrate

DRUG

Hydralazine Hydrochloride

DRUG

Glycerol Trinitrate

DRUG

Phentolamine mesylate

DRUG

Nicardipine

DRUG

Urapidil

DRUG

Esmolol

DRUG

Clonidine

DRUG

Enalaprilat

DRUG

Nitroprusside

Trial Locations (20)

2010

St Vincent's Hospital, Sydney

2050

Royal Prince Alfred Hospital, Sydney

2138

Concord Hospital, Concord

2145

Westmead Hospital, Westmead

2217

St George Hospital, Kogarah

2250

Gosford Hospital, Gosford

2310

John Hunter Hospital, Newcastle

3050

Royal Melbourne Hospital, Melbourne

3065

St Vincent's Hospital, Melbourne

3128

Box Hill Hospital, Melbourne

3181

Alfred Hospital, Melbourne

5000

Royal Adelaide Hospital, Adelaide

6009

Sir Charles Gairdner Hospital, Perth

100034

Regional Coordinating Centre: Peking University First Hospital, Beijing

200025

Regional Coordinating Centre: Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, Shanghai Second Medical University, Shanghai

Unknown

Austin Health, Melbourne

Monash Medical Centre, Melbourne

Hospitals in China, c/o The George Institute China, Beijing

North Shore Hospital, Auckland

Christchurch Hospital, Christchurch

All Listed Sponsors
collaborator

National Health and Medical Research Council, Australia

OTHER

lead

The George Institute

OTHER

NCT00226096 - Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage | Biotech Hunter | Biotech Hunter